Suppr超能文献

TFPACD,一种用于与蛋白质中DCCD位点反应的新型双功能试剂:使用大肠杆菌ATP合酶的研究

TFPACD, a novel bifunctional reagent for reacting with DCCD sites in proteins: studies using Escherichia coli ATP synthase.

作者信息

Phadke A S, Aggeler R, Keana J F, Capaldi R A

机构信息

Department of Chemistry, University of Oregon, Eugene 97403-1229.

出版信息

Biochem Biophys Res Commun. 1994 Jun 15;201(2):635-41. doi: 10.1006/bbrc.1994.1748.

Abstract

A novel cross-linker, 1-[6-(4-azido-2,3,5,6-tetrafluorobenzamido)hexyl]-3-cyclohexylc arbodiimide (TFPACD), has been synthesized and tested by reaction with the Escherichia coli ATP Synthase (ECF1F0). The reagent has a carbodiimide as one reactive group, which is shown to react with ECF1F0 in a similar way to 1,3-dicyclohexylcarbodiimide (DCCD) and modify the beta subunit of the ECF1 part and the c subunit of the F0 part. Reaction with both the ECF1 and F0 parts of the complex inhibited ATPase activity. The second reactive group in the reagent is the photoactivatable tetrafluorophenylazide moiety. Subsequent UV photolysis of TFPACD--modified ECF1 and ECF1F0 led to generation of cross-linked products in significant yields, one between beta and alpha subunits; the second, dimers of the c subunit of the F0 part.

摘要

一种新型交联剂1-[6-(4-叠氮基-2,3,5,6-四氟苯甲酰胺基)己基]-3-环己基碳二亚胺(TFPACD)已被合成,并通过与大肠杆菌ATP合酶(ECF1F0)反应进行了测试。该试剂具有碳二亚胺作为一个反应基团,已证明它与ECF1F0的反应方式与1,3-二环己基碳二亚胺(DCCD)相似,并修饰了ECF1部分的β亚基和F0部分的c亚基。与复合物的ECF1和F0部分反应均抑制了ATP酶活性。该试剂中的第二个反应基团是可光活化的四氟苯基叠氮部分。随后对TFPACD修饰的ECF1和ECF1F0进行紫外光解,导致大量交联产物的生成,一种是β亚基和α亚基之间的交联产物;另一种是F0部分c亚基的二聚体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验